120Jaalouk DE, Lammerding J: Mechantransduction gone awry. Nat Rev Mol Cell Biol 2009;10:63–73.
121Paluch EK, Nelson CM, Biais N, Fabry B, Moller J, Pruitt BL, et al: Mechanotransduction: use the force(s). BMC Biol 2015;4:47.
122Chopra A, Murray ME, Byfield FJ, Mendez MG, Halleluyan R, Restle DJ, et al: Augmentation of integrin-mediated mechanotransduction by hyaluronic acid. Biomaterials 2014;35:71–82.
123Schwartz MA: Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol 2010;2:e005066.
124Sun Z, Guo SS, Fassler R: Integrin-mediated mechanotransduction. J Cell Biol 2016;215:445–456.
125du Roure O, Saez A, Buguin A, Austin RH, Chavrier P, Silberzan P, Ladoux B: Force mapping in epithelial cell migration. Proc Natl Acad Sci USA 2005;102:2390–2395.
126Engler AJ, Sen S, Sweeney HL, Discher DE: Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677–689.
127Vogel V, Sheetz MP: Cell fate regulation by coupling mechanical cycles to biochemical signaling pathways. Curr Opin Cell Biol 2009;21:38–46.
128Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997;137:231–245.
129You L, Cowin SC, Schaffler MB, Weinbaum S: A model for strain amplification in the actin cytoskeleton of osteocytes due to fluid drag on pericellular matrix. J Biomech 2001;34:1375–1386.
130Alenghat FJ, Nauli SM, Kolb R, Zhou J, Ingber DE: Global cytoskeletal control of mechanotransduction in kidney epithelial cells. Exp Cell Res 2004;301:23–30.
131Han Y, Cowin SC, Schaffler MB, Weinbaum S: Mechanotransduction and strain amplification in osteocyte cell processes. Proc Natl Acad Sci U S A 2004;101:16689–16694.
132Hausner T, Nogradi A: The Use of Shock Waves in Peripheral Nerve Regeneration: New Perspectives?; in Guena S, Perroteau I, Tos P, Battiston B (eds): International Review of Neurobiology: Tissue Engineering of The Peripheral Nerve: Biomaterials and Physical Therapy (vol 109). London, Academic Press2013, p 88.
133Raabe O, Shell K, Goessl A, Crispens C, Delhasse Y, Eva A: Effect of extracorporeal shock wave on proliferation and differentiation of equine adipose tissue-derived mesenchymal stem cells in vitro. Am J Stem Cells 2013;2:62–773.
134Leone L, Raffa S, Vetrano M, Ranieri D, Malisan F, Scrofani C, et al: Extracorporeal shock wave treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs).Oncotarget 2016;7:6410–6423.
135Trompetto C, Avanzino L, Bove M, Marinelli L, Molfetta L, Trentini R, et al: External shock waves therapy in dystonia: preliminary results. Eur J Neurol 2009;16:517–521.
136Mori L, Marinelli L, Pelosin E, Curra A, Molfetta L, Abbruzzese G, Trompetto C: Shock waves in the treatment of muscle hypertonia and dystonia. Biomed Res Int 2014;2014:637–450.
137Lee JY, Kim SN, Lee IS, Jung H, Lee KS, Koh SE: Effects of extracorporeal shock wave therapy on spasticity in patients after brain injury: a meta-analysis. J Phy Ther Sci 2014;26:1641–1647.
138Hala A, Gawad A, Karim AEA, Mohammad H: Shock wave therapy for spastic plantar flexor muscles in hemiplegic cerebral palsy children. Egyptian J Human Gen 2015;16:269–275.
139Mirea A, Onose G, Padure L, Rosulescu E: Extracorporeal Shockwave Therapy (ESWT) benefits in spastic children with Cerebral Palsy (CP). J Med Life 2014;7:127–132.
140Park DS, Kwon DR, Park GY, Lee MY: Therapeutic effect of extracorporeal shock wave therapy according to treatment session on gastrocnemius muscle spasticity in children with spastic cerebral palsy: a pilot study. Ann Rehabil Med 2015;39:914–921.
141Vincent KC, d’Agostino MC, Poratt D, Walker M: Utilisation of eswt to restore peripheral vibrosensory perception in a non-sensate Type 1 diabetic foot. 15th Scientific Congress of the International Society for Medical Shockwave Treatment, 4th–7th, Cartegena, Columbia, 2012.
142Chen YL, Chen KH, Yin TC, Huang TH, Yuen CM, Chung SY, et al: Extracorporeal shock wave therapy effectively prevented diabetic neuropathy. Am J Trans Res 2015;7:2543–2560.
143Chen TW, Lin CW, Lee CL, Chen CH, Chen YJ, Lin TY, Huang MH: The efficacy of shock wave therapy in patients with knee osteoarthritis and popliteal cyamellla. Kaohsiung J Med Sci 2014;30:362–370.
144Zhao Z, Jing R, Shi Z, Zhao B, Ai Q, Xing G: Efficacy of extracorporeal shockwave therapy for knee osteoarthritis: a randomized controlled trial. J Surg Res 2013;185:661–666.
145Kim JH, Kim JY, Choi CM, Lee JK, Kee HS, Jung KI, Yoon SR: The dose-related effects of extracorporeal shock wave therapy for knee osteoarthritis. Ann Rehabil Med 2015;39:616–623.
146Vincent KC, Takai B, Craig J, McDonald D: Medical shockwaves for chronic low back pain: a case series. 18th Scientific Congress of the International Society for Medical Shockwave Treatment, 16th–18th, Mendoza, Argentina, July 2015.
147Freitag K: 2016, Uterine Fibroids and Shockwaves. 19th 18th Scientific Congress of the International Society for Medical Shockwave Treatment, 13th–15th July, 2017.
148Craig K, d’Agostino C, Poratt D, Walker M: Original hypothesis: extracorporeal shockwaves as a homeostatic autoimmune restorative treatment (HART) for Type 1 diabetes mellitus. Med Hypotheses 2014;83:250–253.
Kenneth Craig S. Vincent, MD
Kompass Health Associates
27A Haughey Avenue
Three Kings 1042, Aukland (New Zealand)
E-Mail [email protected]
Section II: Musculoskeletal Disorders
Wang C-J, Schaden W, Ko J-Y (eds): Shockwave Medicine.
Transl Res Biomed. Basel, Karger, 2018, vol 6, pp 17–26 (DOI: 10.1159/000485056)
______________________
Development of Extracorporeal Shockwave Therapy for Treatment of Osteonecrosis of the Femoral Head
Jai-Hong Chenga,